Memory Care Costs in Campbell, CA — What You Can Expect to Pay
Cost & Financial Benchmark
Grounded against 7 primary statutory & directory sources.Markdown / Cite ↗
Key Takeaways
Memory care in Campbell, CA typically starts around $7,000/month baseline (CA assisted living median, CareScout Cost of Care Survey 2025). Compare local providers, Medicaid options, and reviews.
Cost Overview
| Service | Min | Max | Unit |
|---|---|---|---|
| Memory Care | $7,000 | $7,000 | per month |
CareScout Cost of Care Survey 2025 (CA assisted living baseline). Actual rates in Campbell may vary.
Memory Care Costs in Campbell, CA
If you're researching memory care costs in Campbell, you're navigating one of the most stressful decisions a family can face — often under time pressure after a fall, a hospital stay, or a sudden decline. With 21 providers in the area, costs vary significantly based on the level of care, the provider's qualifications, and whether you need part-time or round-the-clock support.
A common and costly surprise: Medicare does not cover long-term memory care. It only covers short-term skilled nursing (up to 100 days) after a qualifying hospital stay.[1] For ongoing care, families typically rely on Medicaid (if eligible — and there are often waiting lists), VA benefits, long-term care insurance, or out-of-pocket savings.[1]
Below, we break down what memory care actually costs in Campbell, what's typically included in the price, the hidden fees to watch for, and how families pay for it.
Typical Costs
Memory Care typically costs $7,000 per month (CareScout Cost of Care Survey 2025 CA assisted living median baseline).[1] Actual fees vary depending on the level of care required, the provider, and local market conditions.[1] It is always worth requesting detailed quotes from more than one provider so you can compare like for like.
Help Other Families
Have you or a loved one paid for Memory Care in Campbell? Share your experience to help us build a more transparent market.
Hidden Fees to Ask About
The advertised monthly rate rarely tells the full story. Before signing any agreement, ask about these common additional charges:
- Care level assessments — Many facilities assess your care needs after you sign the lease, then add $500–$2,000/month based on the assessment tier.
- Medication management — Each medication administered can cost $50–$200/month extra. If your loved one takes 8+ medications, this adds up fast.
- Incontinence supplies — Often billed separately at $100–$300/month, even in facilities that include "personal care."
- Laundry service — $50–$100/month in many communities, sometimes only for personal items.
- Transportation — Rides to medical appointments may cost $25–$75 per trip.
- Community fee — A one-time move-in fee of $1,000–$5,000 that is often non-refundable.
Critical question: Ask what happens if your loved one’s savings run out. Some facilities will help transition to Medicaid; others require you to leave within 30 days.
Funding Your Care
Care costs can feel daunting, but there are several routes that may help reduce what you pay out of pocket.
- Medicare — Covers short-term skilled nursing care and limited home health services following a qualifying hospital stay. Does not cover long-term custodial care.
- Medicaid — For those who qualify financially, Medicaid covers nursing home care and, in many states, home and community-based services through waiver programs. Eligibility and benefits vary by state.
- VA Benefits — Veterans and surviving spouses may qualify for Aid and Attendance, which provides a monthly pension supplement to help cover care costs.
- Long-term care insurance — Private policies purchased before the need arises can cover a range of care settings. Review your policy carefully for benefit triggers, daily limits, and elimination periods.
Your Medicare Plan’s Star Rating May Be a Mirage This Year — 3 Things to Check Before Open Enrollment
The window: Medicare Open Enrollment runs October 15 – December 7, 2026, and changes take effect January 1, 2027. This is the one annual window most people have to switch Medicare Advantage or Part D prescription drug plans for 2027.
What actually changed in the ratings formula: CMS’s Contract Year 2027 final rule removed 11 Star Ratings measures — mostly administrative metrics such as call-center performance (including interpreter and TTY availability) and appeals handling — and reinstated the general reward factor in place of the Health Equity Index (HEI). Because fewer operational metrics can pull a composite score down, a plan can show a higher star rating this year without its care having improved at all. CMS’s own regulatory analysis projects roughly $18.5B ($18.56 billion) flowing to plan sponsors over 10 years from these formula and bonus-payment changes. Only one genuinely new clinical measure was added for the 2027 measurement year: depression screening and follow-up.
What families should do — read under the headline star: Check the underlying categories (drug coverage, care coordination, and member experience with the care itself), then verify the three things that actually determine whether a plan works for your parent in 2027:
- Their medications are on the plan’s 2027 formulary at a tolerable tier — confirm every routine prescription, tier placement, and any prior-authorization or step-therapy rules (alongside the finalized 2027 Part D $700 maximum deductible and $2,400 annual out-of-pocket cap).
- Their doctors and hospital are in network for 2027 — provider networks change yearly, so check each primary care physician, specialist, and hospital by name in the plan’s 2027 directory.
- Their pharmacy is preferred in-network — copays at a standard in-network pharmacy can be substantially higher than at a preferred in-network pharmacy under the same plan.
Check stars last, not first. A high-starred plan that drops your parent’s specialist or moves a daily medication to a non-preferred tier will cost your family far more than a lower-starred plan that covers their actual doctors and prescriptions.
Watch for the marketing surge: Federal broker and agent marketing restrictions were loosened effective October 1, 2026, so families should expect a higher volume of calls, mailers, and ads this season — and should know that a sales call is not advice. For free, unbiased guidance with no sales commission, contact your local State Health Insurance Assistance Program (SHIP) counselor, and review our live Medicare Open Enrollment 2026 key dates explainer, 2027 plan-ending checklist, 2027 Medicare costs guide, and FAQ entry (“When is Medicare Open Enrollment for 2026?”) for the dates and plan-ending rules.
Sources & 2027 rule-change explainers: CMS Contract Year 2027 Medicare Advantage and Part D Final Rule Fact Sheet; Medicare Star Ratings 2027 Rule-Change Explainer (Avidon Health, updated 2026-10-03); and 2027 Star Ratings Measure-Set & Reward-Factor Analysis (RISE Health, updated 2026-10-03).
What to Expect
Memory care facilities specialize in supporting people with Alzheimer's disease and other forms of dementia, with secured environments and staff trained in cognitive care techniques.
Cannabis Oil Cut Late-Stage Dementia Agitation in 87% of Patients — What Families Should Know Before Asking Their Doctor
The burden of late-stage agitation: Agitation — pacing, vocal outbursts, restlessness, and acute physical distress — affects roughly half of late-stage dementia patients and is one of the most distressing symptoms families deal with. More than a third of patients keep experiencing severe agitation despite standard prescriptions such as benzodiazepines, opioids, or antipsychotics, all of which carry significant risks of their own in older adults with dementia, including heavy sedation, falls, and FDA boxed warnings.
What the LiBBY trial actually was: LiBBY (Life’s End Benefits of cannaBidiol and tetrahYdrocannabinol) was an NIH-funded Phase 2 randomized, double-blind, placebo-controlled trial of 120 participants, all hospice-eligible with advanced dementia and clinically significant agitation. Participants received a standardized oral combination of 2 mg THC / 100 mg CBD twice daily for 12 weeks (dissolved in digestible oil) or placebo; results were presented at AAIC 2026 (London).
What it found — and the honest safety picture: At week 12, 87.2% of treated patients were rated improved on clinician global impression vs. 23.6% on placebo; the benefit appeared fast (a 6.27-point greater reduction on the CMAI agitation scale at week 2, p=0.0004) and held through week 12 (p<0.0001). Stated plainly alongside that benefit, overall adverse-event rates were similar to placebo (46.7% vs. 42.4%), but serious adverse events were higher in the treatment arm (23.3% vs. 11.9%), and deaths were 13.1% vs. 5.1% with no specific cause pattern — numbers that must be read in the context of an end-of-life population, and that families deserve to see unspun.
What to ask the doctor:
- Is agitation like my parent’s the kind this trial studied? (LiBBY studied hospice-eligible, late-stage dementia patients with clinically significant agitation — not earlier-stage wandering or mild sundowning.)
- What have we already tried, and what did it cost them? Review non-drug comfort measures and current medications, including whether sedatives or antipsychotics are causing side effects without relieving distress.
- If we were interested, what would the legal and hospice-policy position be in our state and with our hospice? State laws, facility licensing rules, and hospice protocols vary widely.
- What interactions with current sedatives or opioids would we watch for? Oral THC and CBD can amplify sedation, dizziness, and drug levels when combined with benzodiazepines, opioids, or antipsychotics.
- What would we monitor, and when would we stop? Agree in advance on specific target symptoms, side-effect warning signs, and a clear stopping rule.
Essential caveats for families: This evidence comes from a single Phase 2 trial in a hospice-eligible end-of-life population only; the studied oral THC/CBD formulation is not a prescription option today; there is no long-term data beyond the 12-week trial; and the legal status of THC/CBD products varies by state. Commercial dispensary or over-the-counter CBD/THC products are not equivalent to a standardized clinical-trial formulation, and nothing in this section is a recommendation to obtain or use cannabis products.
Sources: Psychiatric Times: Oral Cannabinoid From MediPharm Shows Significant Reduction in Agitation in Alzheimer Disease and Dementia (2026-10-03); and The Educated Patient: A CBD/THC Combination Reduced Dementia Agitation in Nearly 9 in 10 Patients (2026-10-04).
Finding Regulated Providers
Memory Care providers are regulated by State licensing boards. Before choosing a provider in Campbell, check their latest quality rating and inspection reports. You can also browse and compare providers on families.care.
Find care providers in Campbell, CA
Browse profiles, compare ratings, and connect with local providers.
Not sure where to start?
Answer a few questions and get personalised care recommendations.
Verified references & primary sources
7 verified sourcesQuantitative and regulatory claims in this guide are grounded against official registries and benchmark datasets.
-
Statutory RegistryCareScout · Verified 2026-08-15 · General senior-care planning information.
“A common and costly surprise: Medicare does not cover long-term memory care.”
-
Statutory RegistryMedicare.gov · Verified 2026-08-15 · General senior-care planning information.
-
Statutory RegistryMedicaid.gov · Verified 2026-07-10 · General senior-care planning information.
-
Statutory RegistryNational Institute on Aging · Verified 2026-07-10 · General senior-care planning information.
-
Statutory RegistryU.S. Department of Veterans Affairs · Verified 2026-08-15 · General senior-care planning information.
-
Statutory RegistryWorld Bank · Verified 2026-08-07 · National health spending, share of population aged 65+, consumer-price inflation, GDP per capita, old-age dependency ratio, and government share of health spending.
-
Statutory RegistryInternational Monetary Fund · Verified 2026-08-07 · Consumer-price inflation forecast for the current year.
How we research and verify this information
Our team compiles this listing from public records and provider data, and reviews it against authoritative sources. Read our editorial standards and research methodology.
- Cost of Care Survey (2025)Publisher: CareScout. Supports: General public-program and care-cost context; not a local price quote. Last checked: 2026-08-15.
- Skilled nursing facility coveragePublisher: Medicare.gov. Supports: General public-program and care-cost context; not a local price quote. Last checked: 2026-08-15.
- Medicaid coverage and eligibilityPublisher: Medicaid.gov. Supports: General public-program and care-cost context; not a local price quote. Last checked: 2026-07-10.
- Long-term-care guidance for familiesPublisher: National Institute on Aging. Supports: General public-program and care-cost context; not a local price quote. Last checked: 2026-07-10.
- VA pension rates (Aid & Attendance)Publisher: U.S. Department of Veterans Affairs. Supports: General public-program and care-cost context; not a local price quote. Last checked: 2026-08-15.